社论：推动质量调整生命年前进还是只是陷入困境？ - Suppr

Suppr

超能文献

Editorial: Moving the QALY forward or just stuck in traffic?

作者信息

Johnson F Reed

出版信息

Value Health. 2009 Mar;12 Suppl 1:S38-9. doi: 10.1111/j.1524-4733.2009.00521.x.

DOI:10.1111/j.1524-4733.2009.00521.x

PMID:19250131

Abstract

摘要

相似文献

Editorial: Moving the QALY forward or just stuck in traffic?社论：推动质量调整生命年前进还是只是陷入困境？

Value Health. 2009 Mar;12 Suppl 1:S38-9. doi: 10.1111/j.1524-4733.2009.00521.x.

Moving the QALY forward: rationale for change.推动质量调整生命年（QALY）的发展：变革的理由。

Value Health. 2009 Mar;12 Suppl 1:S1-4. doi: 10.1111/j.1524-4733.2009.00514.x.

Editorial: On the benefits of modeling using QALYs for societal resource allocation: the model is the message.社论：关于使用质量调整生命年（QALYs）进行社会资源分配建模的益处：模型即信息。

Value Health. 2009 Mar;12 Suppl 1:S36-7. doi: 10.1111/j.1524-4733.2009.00520.x.

The use of quality-adjusted life-years in cost-effectiveness studies.质量调整生命年在成本效益研究中的应用。

Allergy. 2006 May;61(5):527-30. doi: 10.1111/j.1398-9995.2006.01053.x.

Retaining, and enhancing, the QALY.保留并提高质量调整生命年。

Value Health. 2009 Mar;12 Suppl 1:S18-26. doi: 10.1111/j.1524-4733.2009.00518.x.

What do utilities measure?效用衡量的是什么？

Med Care. 2000 Sep;38(9 Suppl):II160-4.

Toward a consensus on the QALY.就质量调整生命年达成共识。

Value Health. 2009 Mar;12 Suppl 1:S31-5. doi: 10.1111/j.1524-4733.2009.00522.x.

Calculation of quality adjusted life years in the published literature: a review of methodology and transparency.已发表文献中质量调整生命年的计算：方法与透明度综述

Health Econ. 2004 Dec;13(12):1203-10. doi: 10.1002/hec.901.

Preferences for health outcomes and cost-utility analysis.对健康结果的偏好与成本效用分析。

Am J Manag Care. 1997 May;3 Suppl:S8-20.

Are decisions using cost-utility analyses robust to choice of SF-36/SF-12 preference-based algorithm?使用成本效用分析做出的决策对于SF - 36/SF - 12基于偏好的算法选择是否稳健？

Health Qual Life Outcomes. 2005 Mar 4;3:11. doi: 10.1186/1477-7525-3-11.

引用本文的文献

The economic burden of child sexual abuse in the United States.美国儿童性虐待的经济负担。

Child Abuse Negl. 2018 May;79:413-422. doi: 10.1016/j.chiabu.2018.02.020. Epub 2018 Mar 20.

Current challenges in health economic modeling of cancer therapies: a research inquiry.癌症治疗健康经济模型中的当前挑战：一项研究探讨。

Am Health Drug Benefits. 2014 May;7(3):153-62.

Economic return from the Women's Health Initiative estrogen plus progestin clinical trial: a modeling study.妇女健康倡议雌激素加孕激素临床试验的经济回报：一项建模研究。

Ann Intern Med. 2014 May 6;160(9):594-602. doi: 10.7326/M13-2348.

Assessing patient preferences for treatment options and process of care in inflammatory bowel disease: a critical review of quantitative data.评估炎症性肠病患者对治疗方案和护理过程的偏好：定量数据分析的批判性回顾。

Patient. 2013;6(4):241-55. doi: 10.1007/s40271-013-0031-2.

Stakeholder perspectives on a risk-benefit framework for genetic testing.利益相关者对基因检测风险-收益框架的看法。

Public Health Genomics. 2011;14(2):59-67. doi: 10.1159/000290452. Epub 2010 Apr 20.

Using qualitative methods to inform the trade-off between content validity and consistency in utility assessment: the example of type 2 diabetes and Alzheimer's disease.采用定性方法权衡效用评估中的内容效度和一致性：以 2 型糖尿病和阿尔茨海默病为例。

Health Qual Life Outcomes. 2010 Feb 12;8:23. doi: 10.1186/1477-7525-8-23.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验